Litigation

Recent Posts

2 Drug Makers To Pay $214.5 Million For Off-Label Marketing Of Zonegran
Posted on 16 Dec 2010 by Tom Moylan

BOSTON - (Mealey's) Drug maker Elan Corp. PLC on Dec. 15 pleaded guilty to misdemeanor branding for the off-label marketing of the epilepsy drug Zonegran and will pay more than $203.5 million in criminal and civil penalties ( United States of America... Read More